These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2567526)

  • 21. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.
    Barasi S; Ben-Sreti MM; Clatworthy AL; Duggal KN; Gonzalez JP; Robertson J; Rooney KF; Sewell RD
    Br J Pharmacol; 1987 Jan; 90(1):15-22. PubMed ID: 3545350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine autoreceptor sensitivity is unchanged in rat nucleus accumbens after chronic haloperidol treatment: an in vivo and in vitro voltammetric study.
    Chesi AJ; Feasey-Truger KJ; Alzheimer C; ten Bruggencate G
    Eur J Neurosci; 1995 Dec; 7(12):2450-7. PubMed ID: 8845950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
    Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
    Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J; Desiraju T; Raju TR
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
    de Bruin NM; Ellenbroek BA; van Luijtelaar EL; Cools AR; Stevens KE
    Neuroscience; 2001; 105(1):169-80. PubMed ID: 11483310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated treatment with imipramine enhances the excitatory response of hippocampal neurons to dopamine.
    Smiałowski A; Bijak M
    Neuroscience; 1987 Dec; 23(3):1021-4. PubMed ID: 2963971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zetidoline, a novel neuroleptic, activates nigral dopaminergic neurons in rats.
    Mereu G; Fanni B; Collu M; Diena A; Glasser A
    Life Sci; 1985 Feb; 36(5):459-64. PubMed ID: 2857469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
    Lokhandwala MF; Steenberg ML
    J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA; Pokora MJ; Widzowski DV
    Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated amphetamine: reduced dopamine neuronal responsiveness to apomorphine but not quinpirole.
    Pitts DK; Freeman AS; Kelland MD; Chiodo LA
    Eur J Pharmacol; 1989 Mar; 162(1):167-71. PubMed ID: 2566494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements.
    Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M
    Eur J Pharmacol; 1994 Jan; 252(1):99-104. PubMed ID: 7908646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
    Prosser ES; Pruthi R; Csernansky JG
    Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of D2 dopamine agonists on tuberoinfundibular dopamine neurons.
    Berry SA; Gudelsky GA
    Neuropharmacology; 1991 Sep; 30(9):961-5. PubMed ID: 1681453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol.
    Vogelsang GD; Piercey MF
    Eur J Pharmacol; 1985 Apr; 110(2):267-9. PubMed ID: 3987817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
    Godbout R; Mantz J; Pirot S; Glowinski J; Thierry AM
    J Pharmacol Exp Ther; 1991 Aug; 258(2):728-38. PubMed ID: 1865369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.